Enigmatic variation
Variability in presentation and prognosis of transient myeloproliferative disorder (TMD) in infants with Down syndrome (DS) has perplexed clinicians and scientists for decades and is explored in this issue of Blood by Gamis and colleagues from the Children's Oncology Group (COG).
| Auteurs principaux: | , |
|---|---|
| Format: | Journal article |
| Langue: | English |
| Publié: |
American Society of Hematology
2011
|